Document Detail

beta-Endorphin in the median preoptic nucleus modulates the pressor response induced by subcutaneous hypertonic sodium chloride.
MedLine Citation:
PMID:  18021772     Owner:  NLM     Status:  MEDLINE    
Considerable evidence has been gathered involving the endogenous opioid system in blood pressure regulation. In the present study, we investigated the effect of administering beta-Endorphin into the median preoptic nucleus (MnPO) on blood pressure (BP) and heart rate (HR) and whether this administration was capable of modulating the pressor response observed after an acute increase in plasma osmolality. In urethane-anaesthetized Wistar rats, different doses of beta-Endorphin (1, 10, 25 ng) were microinjected into the MnPO to elucidate a putative role for beta-Endorphin in BP and HR regulation. Additionally, we evaluated the modulatory effect of the beta-Endorphin injection (25 ng) into the MnPO on the pressor response to subcutaneous sodium chloride solution administration (2 M NaCl, 0.1 ml/10 gbw). The MnPO-beta-Endorphin microinjection resulted in a dose-dependent hypotensive and bradycardic effect and pre-treatment with the opioid antagonist, naloxone (100 ng), injected in the same nucleus, significantly antagonized the cardiovascular response to beta-Endorphin administration in the MnPO. On the other hand, a microinjection of beta-Endorphin (25 ng) into the median preoptic nucleus abolished the pressor response to a subcutaneous injection of hypertonic saline. It is concluded from these results that beta-Endorphin-MnPO administration produces a decrease in BP and HR in normotensive animals and also inhibits the pressor response evoked by an acute increase in plasma osmolality.
Ximena Caeiro; Laura Vivas
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-10-10
Journal Detail:
Title:  Experimental neurology     Volume:  210     ISSN:  0014-4886     ISO Abbreviation:  Exp. Neurol.     Publication Date:  2008 Mar 
Date Detail:
Created Date:  2008-02-25     Completed Date:  2008-05-02     Revised Date:  2008-05-16    
Medline Journal Info:
Nlm Unique ID:  0370712     Medline TA:  Exp Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  59-66     Citation Subset:  IM    
Instituto de Investigación Médica Mercedes y Martín Ferreyra (INIMEC-CONICET), Córdoba, Argentina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Blood Pressure / drug effects*
Dose-Response Relationship, Drug
Drug Interactions
Heart Rate / drug effects
Injections, Subcutaneous / methods
Naloxone / pharmacology
Narcotic Antagonists / pharmacology
Osmolar Concentration
Plasma / drug effects
Preoptic Area / drug effects*
Rats, Wistar
Saline Solution, Hypertonic / pharmacology*
Time Factors
beta-Endorphin / pharmacology*
Reg. No./Substance:
0/Narcotic Antagonists; 0/Saline Solution, Hypertonic; 465-65-6/Naloxone; 60617-12-1/beta-Endorphin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neuroprotective and axon growth promoting effects of intraocular inflammation do not depend on oncom...
Next Document:  Trypanosoma brucei: differential requirement of membrane potential for import of proteins into mitoc...